<DOC>
	<DOCNO>NCT02826382</DOCNO>
	<brief_summary>A phase 0 study demonstrate [ 68Ga ] P15-041 bind bone metastasis prostate cancer determination human dosimetry .</brief_summary>
	<brief_title>Preliminary Evaluation Uptake Bone Metastases Biodistribution 68GaP15-041</brief_title>
	<detailed_description />
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Bone Neoplasms</mesh_term>
	<mesh_term>Bone Marrow Diseases</mesh_term>
	<criteria>histologically confirm prostate cancer . know suspect bone metastasis refer clinical [ 99mTc ] MDP scan Estimated creatinine clearance ( GFR ) &lt; 30 mL/min ( calculate ) , history hyperparathyroidism , • Inability tolerate image procedure opinion investigator treat physician , • Any current medical condition , illness , disorder assess medical record review and/or selfreported consider physician investigator condition could compromise participant safety successful participation study</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>